Silence Therapeutics Competitors and Similar CompaniesClear all

Silence Therapeutics's competitors and similar companies include Abingdon Health, Foundation Laboratory, Maryland Urgent Care and Clemson Eye.

	Silence Therapeutics Silence Therapeutics is a therapeutics company that develops novel, proprietary short-interfering RNA.	Abingdon Health Abingdon Health is a specialist medical diagnostics company that acquires, develops and distributes diagnostic tools and services.	Foundation Laboratory Foundation Laboratory is a clinical diagnostic laboratory.	Maryland Urgent Care Maryland Urgent Care & Primary Care is a medical clinic and testing facility offering immediate medical treatment and primary care services.	Clemson Eye Clemson Eye is a company providing medical and surgical eye care.
Founding Date	Founding Date 1999	Founding Date 2008	Founding Date 1966	Founding Date 2002	Founding Date 1970
Type	Type Public	Type Private	Type Private	Type Private	Type Subsidiary
Tags	Tags Healthcare clinics medical diagnostics	Tags Healthcare clinics medical diagnostics	Tags Healthcare clinics medical diagnostics	Tags Healthcare clinics medical diagnostics	Tags Healthcare clinics medical diagnostics
Locations	Locations London, GB HQ Berlin, DE London, GB Hoboken, US New York, US	Locations North Yorkshire, GB HQ	Locations Pomona, US HQ	Locations Lanham, US HQ	Locations Anderson, US HQ Clemson, US Easley, US Greenville, US Greenville, US Saluda, US Simpsonville, US
Employees	Employees 6589% decrease	Employees 79	Employees 1382% increase	Employees 5	Employees 114
Financial
Revenue (est.)	Revenue (est.) $559k (FY, 2025)	Revenue (est.) £2.3m (FY, 2018)	Revenue (est.) N/A	Revenue (est.) N/A	Revenue (est.) N/A
Cost of goods	Cost of goods $215k (FY, 2025)	Cost of goods £583.1k (FY, 2018)	Cost of goods N/A	Cost of goods N/A	Cost of goods N/A
Gross profit	Gross profit $344k (FY, 2025)	Gross profit £1.7m (FY, 2018)	Gross profit N/A	Gross profit N/A	Gross profit N/A
Net income	Net income ($88.6m) (FY, 2025)	Net income £3.5m (FY, 2018)	Net income N/A	Net income N/A	Net income N/A